Literature DB >> 26958031

Occurrence of aminoglycoside-modifying enzymes genes (aac(6')-I and ant(2″)-I) in clinical isolates of Pseudomonas aeruginosa from Southwest Nigeria.

Bamidele Tolulope Odumosu1, Bolanle A Adeniyi2, Ram Chandra3.   

Abstract

BACKGROUND: Enzymatic modification of aminoglycosides is the primary mechanism of resistance by Pseudomonas aeruginosa. OBEJECTIVES: We investigated the occurrence and mechanism of aminoglycosides resistance in P. aeruginosa isolates from hospitals in SouthWest Nigeria.
METHODS: A total of 54 consecutive, non-duplicate clinical isolates of P. aeruginosa were studied for the presence of aminoglycosides -modifying enzymes (AMEs) by PCR amplification and sequencing of genes encoding AMEs. RESULTS AND
CONCLUSION: Two types of AME genes [aac (6') - I and ant (2″) - I] were found in 12 isolates out of 54. Seven strains harboured one or more types of enzymes of which aac (6') - I was the most frequently found gene (10/54 isolates, 18.5%). None of the isolates investigated in this study were positive for aph, aac (3) and aac (6″) - II genes. Prevalence of P. aeruginosa producing AME genes in this study may suggest aminoglycosides use in Nigeria. This study highlights need for functional antimicrobial surveillance system in Nigeria.

Entities:  

Keywords:  Aminoglycoside-modifying enzymes; Pseudomonas aeruginosa; antibiotics resistance

Mesh:

Substances:

Year:  2015        PMID: 26958031      PMCID: PMC4765422          DOI: 10.4314/ahs.v15i4.29

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  15 in total

Review 1.  Aminoglycoside resistance in Pseudomonas aeruginosa.

Authors:  Keith Poole
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

Review 2.  Efflux-mediated antimicrobial resistance.

Authors:  Keith Poole
Journal:  J Antimicrob Chemother       Date:  2005-05-24       Impact factor: 5.790

3.  Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact.

Authors:  Valerie Aloush; Shiri Navon-Venezia; Yardena Seigman-Igra; Shaltiel Cabili; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

4.  Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System.

Authors:  M J Richards; J R Edwards; D H Culver; R P Gaynes
Journal:  Crit Care Med       Date:  1999-05       Impact factor: 7.598

5.  The most frequent aminoglycoside resistance mechanisms--changes with time and geographic area: a reflection of aminoglycoside usage patterns? Aminoglycoside Resistance Study Groups.

Authors:  G H Miller; F J Sabatelli; R S Hare; Y Glupczynski; P Mackey; D Shlaes; K Shimizu; K J Shaw
Journal:  Clin Infect Dis       Date:  1997-01       Impact factor: 9.079

6.  Risk factors for ventilator-associated pneumonia by Pseudomonas aeruginosa in presence of recent antibiotic exposure.

Authors:  Jordi Rello; Camilla Allegri; Alejandro Rodriguez; Loreto Vidaur; Gonzalo Sirgo; Frederic Gomez; Kemal Agbaht; Angel Pobo; Emili Diaz
Journal:  Anesthesiology       Date:  2006-10       Impact factor: 7.892

7.  Molecular characterization of a novel class 1 integron containing bla(GES-1) and a fused product of aac3-Ib/aac6'-Ib' gene cassettes in Pseudomonas aeruginosa.

Authors:  Véronique Dubois; Laurent Poirel; Caroline Marie; Corinne Arpin; Patrice Nordmann; Claudine Quentin
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

Review 8.  Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes.

Authors:  K J Shaw; P N Rather; R S Hare; G H Miller
Journal:  Microbiol Rev       Date:  1993-03

9.  16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides.

Authors:  Yohei Doi; Yoshichika Arakawa
Journal:  Clin Infect Dis       Date:  2007-05-21       Impact factor: 9.079

10.  Analysis of integrons and associated gene cassettes in clinical isolates of multidrug resistant Pseudomonas aeruginosa from Southwest Nigeria.

Authors:  Bamidele T Odumosu; Bolanle A Adeniyi; Ram Chandra
Journal:  Ann Clin Microbiol Antimicrob       Date:  2013-10-21       Impact factor: 3.944

View more
  6 in total

1.  Effect of solvent and protein dynamics in ligand recognition and inhibition of aminoglycoside adenyltransferase 2″-Ia.

Authors:  Valjean R Bacot-Davis; Angelia V Bassenden; Tara Sprules; Albert M Berghuis
Journal:  Protein Sci       Date:  2017-07-21       Impact factor: 6.725

2.  Application of protein typing in molecular epidemiological investigation of nosocomial infection outbreak of aminoglycoside-resistant Pseudomonas aeruginosa.

Authors:  Min Song; Min Tang; Yinghuan Ding; Zecai Wu; Chengyu Xiang; Kui Yang; Zhang Zhang; Baolin Li; Zhenghua Deng; Jinbo Liu
Journal:  Environ Sci Pollut Res Int       Date:  2017-12-16       Impact factor: 4.223

3.  Genotypic Characterization of Aminoglycoside Resistance Genes from Bacteria Isolates in Selected Municipal Drinking Water Distribution Sources in Southwestern Nigeria.

Authors:  Ayodele T Adesoji; Isaac O Olatoye; Adeniyi A Ogunjobi
Journal:  Ethiop J Health Sci       Date:  2019-05

4.  A rapid and accurate method for the detection of four aminoglycoside modifying enzyme drug resistance gene in clinical strains of Escherichia coli by a multiplex polymerase chain reaction.

Authors:  Yaoqiang Shi; Chao Li; Guangying Yang; Xueshan Xia; Xiaoqin Mao; Yue Fang; A-Mei Zhang; Yuzhu Song
Journal:  PeerJ       Date:  2020-04-10       Impact factor: 2.984

5.  Antibiotic susceptibility pattern and analysis of plasmid profiles of Pseudomonas aeruginosa from human, animal and plant sources.

Authors:  Bamidele Tolulope Odumosu; Olabayo Ajetunmobi; Hannah Dada-Adegbola; Idowu Odutayo
Journal:  Springerplus       Date:  2016-08-22

Review 6.  Pathogenesis of the Pseudomonas aeruginosa Biofilm: A Review.

Authors:  Felipe Francisco Tuon; Leticia Ramos Dantas; Paula Hansen Suss; Victoria Stadler Tasca Ribeiro
Journal:  Pathogens       Date:  2022-02-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.